Affiliation:
1. P.A. Herzen Moscow Research Oncology Institute – branch of the National Medical Research Radiological Center, Ministry of Health of Russia
Abstract
Currently, stratification of recurrence risk and prognosis of 5-year survival of patients with soft tissue sarcomas are primarily based on histological tumor classification. Drawing from these data, international oncological societies have proposed a hypothesis about development of gene expression profiling and molecular and genetic diagnosis technologies which will allow to more accurately assess risks of soft tissue sarcoma development and select individual drug treatment.
Publisher
Publishing House ABV Press